Company intelligence / Profile preview

Vivolta

Waalre, Noord-Brabant, Netherlands

Ownership: Private
Development stage: Other

Overview

Vivolta is a pioneering leader in automated electrospun medical product manufacturing, facilitating scalable and quality-assured medical devices. Its technology underpins both commercial products and clinical-stage programs in cardiovascular, orthopedic, and CNS drug delivery applications. Its proprietary MediSpin™ platform enables reproducible, operator-independent device production. Recent partnerships include Neurochase, whose CNS drug delivery device is expected to enter clinical trials in 2025.

Therapeutic areas: NeurologyCardiovascularOther
Modalities: DeviceNanofiber-based therapyHydrogel-based drug delivery therapyPolymer-drug conjugate therapy
Industry: Implantable Medical Devices

Partnerships

Neurochase (exclusive manufacturing of electrospun micro-catheter for CNS drug delivery)

Beyond the preview

Go deeper on Vivolta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivolta.

Explore the full profile